| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 780 | ₹0.8 0% | 19,3750% |
| - | - | 800 | ₹0.95 5.55% | 67,425-1.13% |
| - | - | 820 | ₹2 0% | 3,8750% |
| 1,5500% | ₹89.05 0% | 830 | ₹2 0% | 3,1000% |
| - | - | 840 | ₹3 0% | 19,3750% |
| 9,3000% | ₹69 0% | 850 | ₹3.15 0% | 68,200-9.27% |
| 00% | ₹60 0% | 860 | ₹5.35 6.99% | 20,9250% |
| - | - | 870 | ₹6.05 5.21% | 31,77528.12% |
| 7,7500% | ₹45.45 0.33% | 880 | ₹7.7 -4.34% | 1,61,97513.58% |
| 3,8750% | ₹32.25 0% | 890 | ₹9.6 0% | 38,7500% |
| 1,74,375-2.59% | ₹28.8 -3.67% | 900 | ₹13.75 -3.84% | 2,60,400-6.92% |
| 1,19,350-3.14% | ₹22.95 -4.37% | 910 | ₹17.55 -3.03% | 95,325-10.21% |
| 1,83,675-2.46% | ₹18.25 -3.43% | 920 | ₹22.8 0.21% | 1,55,000-6.54% |
| 1,34,8504.19% | ₹14.05 -3.76% | 930 | ₹26.65 -8.41% | 44,950-13.43% |
| 1,78,2500.43% | ₹10.45 -5% | 940 | ₹37 0% | 32,5500% |
| 3,07,6752.84% | ₹8.05 -6.39% | 950 | ₹43 3.61% | 88,3500% |
| 86,025-7.5% | ₹5.85 -10.68% | 960 | ₹53 0% | 12,4000% |
| 43,40021.73% | ₹4.6 1.09% | 970 | ₹56.8 0% | 1,5500% |
| 84,475-10.65% | ₹3.15 -18.18% | 980 | ₹53.85 0% | 6,9750% |
| 15,5000% | ₹2.8 0% | 990 | - | - |
| 1,56,5503.06% | ₹1.9 -13.63% | 1,000 | ₹85.7 -1.94% | 26,3500% |
| 37,2000% | ₹1.35 0% | 1,020 | - | - |
| 11,6250% | ₹0.7 0% | 1,040 | - | - |
| - | - | 1,050 | ₹136.25 0% | 7,7500% |
| 2,3250% | ₹0.7 0% | 1,080 | - | - |
| 6,9750% | ₹0.5 11.11% | 1,100 | ₹177 0% | 4,6500% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
